Clinical Trial Update: Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for tivanisiran in dry eye due to Sjögren's syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Sjögren Syndrome

Drugs mentioned

• tivanisiran

Snippet

Sponsor: Sylentis, S.A. | Conditions: Dry Eye Disease, Sjögren Syndrome | Phase 3 | Status: COMPLETED